tiprankstipranks
Trending News
More News >

Sanofi India Secures Court Approval for Export Rebate Claim

Story Highlights
  • Sanofi India operates in the pharmaceutical industry, offering medicines and vaccines.
  • Gujarat High Court approved Sanofi India’s refund claim, with no material impact on operations.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Sanofi India Secures Court Approval for Export Rebate Claim

Confident Investing Starts Here:

Sanofi India Limited ( (IN:SANOFI) ) has provided an update.

Sanofi India Limited announced that the Gujarat High Court has allowed its writ petition for a refund claim of Rs. 83,74,925 for the year 2014. The court directed the company to submit necessary documents to the jurisdictional authority for a rebate claim on export. This decision does not have a material impact on the company’s financial, operational, or other activities.

More about Sanofi India Limited

Sanofi India Limited operates in the pharmaceutical industry, providing a range of healthcare solutions including prescription medicines and vaccines. The company focuses on improving patient health and has a significant presence in the Indian market.

YTD Price Performance: -4.20%

Average Trading Volume: 2,245

Current Market Cap: 131.9B INR

For detailed information about SANOFI stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1